WebMD Drug Updates Approvals Stay up to date on the FDA drug approval pipeline including newly approved medications, updated indications and the timeline of their approval
Drug Approvals and Databases | FDA Downloadable data files FDA Adverse Event Reporting System (FAERS) Public Dashboard Inactive Ingredient Search for Approved Drug Products Search More information Medication Guides Search More
Rare Disease Drug Approvals | FDA This page describes recent rare disease drug approvals that received a CDER or FDA communication This is not an exhaustive list of all rare disease drug approvals
FDA-Approved Treatments for Alzheimers FDA-Approved Drugs For Alzheimer's The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia
6 New Kidney Disease Medications Approved In 2025 In 2025, the FDA approved new kidney disease medications for CKD, IgAN, C3G, lupus nephritis, and more Learn how these treatments may help protect kidney health
New FDA Approved Alzheimers Treatments - Cleveland . . . The U S Food and Drug Administration (FDA) has approved several medications for the treatment of individuals with early-stage Alzheimer’s disease Below are recent updates on FDA-approved therapies, including information on indications, administration, clinical trial findings, and important safety considerations
FDA Approves Rezdiffra, the First Drug for MASH, a Form of . . . Rates of a serious form of liver disease have grown, but there have been no medications to treat it—until now In March, the U S Food and Drug Administration (FDA) approved a pill called resmetirom, sold under the brand name Rezdiffra™, for NASH (nonalcoholic steatohepatitis)
6 Rare Diseases That Have New FDA-Approved Treatments An estimated 7,000 of these conditions have been identified, and more than 90% of them have no FDA-approved treatment Yet progress toward developing such treatments continues, particularly among smaller companies Here are five rare diseases that have seen drug approvals since last year’s Rare Disease Day